Current Treatment Options for Cognitive Impairment in Bipolar Disorder: a Review

被引:0
|
作者
Douglas K.M. [1 ]
Van Rheenen T.E. [2 ,3 ,4 ]
机构
[1] Department of Psychological Medicine, University of Otago, Christchurch, PO Box 4345, Christchurch
[2] Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne, 161 Barry St, Carlton, 3053, VIC
[3] Brain and Psychological Sciences Research Centre, School of Health Sciences, Swinburne University, Melbourne
[4] Cognitive Neuropsychiatry Laboratory, Monash Alfred Psychiatry Research Centre, The Alfred Hospital and Central Clinical School, Monash University, Melbourne
基金
英国医学研究理事会;
关键词
Bipolar disorder; Cognitive function; Cognitive remediation; Cognitive treatment; Executive function; Memory;
D O I
10.1007/s40501-016-0092-7
中图分类号
学科分类号
摘要
Cognitive impairment is a key feature of bipolar disorder (BD) which often persists into euthymia. This impairment appears to be independent, to an extent, of mood symptoms and is associated with deficits in overall functioning. Priority should thus be given to research investigating adjunctive treatments aimed at improving cognitive functioning in BD. This paper systematically reviews studies specifically examining changes in cognitive functioning in relation to pharmacological and/or psychosocial interventions in adults with BD. Eighteen studies were included in the review: 11 examining pharmacological interventions and seven examining psychosocial interventions. Findings from the reviewed studies were mixed but generally did not produce evidence of widespread cognitive improvement at treatment end in line with widespread cognitive impairment considered to be a key feature of BD. It is, however, difficult to draw conclusions from the research to date due to the general scarcity of studies in the area, small sample sizes, minimal replication of studies examining the same intervention and variability in study designs. Future research in the area would benefit greatly from investigating the current reviewed interventions in large-scale RCTs. An understanding of what particular subgroups of BD patients gain most benefit from cognitive interventions would be of clinical use. © 2016, Springer International Publishing AG.
引用
收藏
页码:330 / 355
页数:25
相关论文
共 50 条
  • [41] Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder: a systematic review
    Cullen, B.
    Ward, J.
    Graham, N.
    Deary, I.
    Pell, J.
    Smith, D.
    Evans, J.
    BIPOLAR DISORDERS, 2016, 18 : 135 - 135
  • [42] Chemotherapy and Cognitive Impairment: Treatment Options
    Fardell, J. E.
    Vardy, J.
    Johnston, I. N.
    Winocur, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (03) : 366 - 376
  • [43] Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence
    Van Rheenen, Tamsyn E.
    Lewandowski, Kathryn E.
    Bauer, Isabelle E.
    Kapczinski, Flavio
    Miskowiak, Kamilla
    Burdick, Katherine E.
    Balanza-Martinez, Vicent
    BIPOLAR DISORDERS, 2020, 22 (01) : 13 - 27
  • [44] Melatonin and Cognitive Deficits in Bipolar Disorder and Mild Cognitive Impairment
    Anderson, George
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (04) : 244 - 244
  • [45] Treatment options for acute depression in bipolar disorder
    Bauer, Michael
    Ritter, Philipp
    Grunze, Heinz
    Pfennig, Andrea
    BIPOLAR DISORDERS, 2012, 14 : 37 - 50
  • [46] An update on adjunctive treatment options for bipolar disorder
    Dean, Olivia M.
    Gliddon, Emma
    Van Rheenen, Tamsyn E.
    Giorlando, Francesco
    Davidson, Sandra K.
    Kaur, Manreena
    Ngo, Trung T.
    Williams, Lana J.
    BIPOLAR DISORDERS, 2018, 20 (02) : 87 - 96
  • [47] Treatment options for acute depression in bipolar disorder
    Bauer, M.
    BIPOLAR DISORDERS, 2012, 14 : 21 - 21
  • [48] Cognitive impairment and sleep disturbance in bipolar disorder: Are they related?
    Miskowiak, Kamilla
    BIPOLAR DISORDERS, 2023, 25 : 21 - 22
  • [49] Cognitive impairment in schizophrenia and bipolar disorder during the lifetime
    Pandova, M.
    Hranov, L. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S332 - S333
  • [50] Prevalence of cognitive impairment in major depression and bipolar disorder
    Douglas, Katie M.
    Gallagher, Peter
    Robinson, Lucy J.
    Carter, Janet D.
    McIntosh, Virginia V. W.
    Frampton, Christopher M. A.
    Watson, Stuart
    Young, Allan H.
    Ferrier, I. Nicol
    Porter, Richard J.
    BIPOLAR DISORDERS, 2018, 20 (03) : 260 - 274